COMMUNIQUÉS West-GlobeNewswire

Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
24/09/2025
- 86% overall survival (OS) observed at 9 months; standard of care benchmark is ~47% - - 53% progression-free survival (PFS) observed at 9 months; standard of care benchmark is ~29% - - Company expects regulatory [...]
CROSSJECT présente ses résultats financiers et les principaux faits marquants pour le premier semestre 2025
24/09/2025
Communiqué de presse CROSSJECT présente ses résultats financiers et les principaux faits marquants pour le premier semestre 2025 Position de trésorerie : 6.3 millions d'euros, contre 7,0 millions d’euros au 31 décembre [...]
CROSSJECT presents its financial results and key highlights for the first half of 2025
24/09/2025
Press release CROSSJECT presents its financial results and key highlights for the first half of 2025 Cash position: €6.3 million, compared to €7.0 million as of December 31 2024, demonstrating the Company's excellent [...]
Inventiva to Host Analyst and Investor Event on October 8, 2025
24/09/2025
Program will include an update on the Company’s lead asset, lanifibranor, ahead of anticipated Phase 3 NATiV3 topline results in the second half of 2026 Three renowned international experts and a patient representative [...]
Inventiva organise un événement analystes et investisseurs le 8 octobre 2025
24/09/2025
Le programme inclura une mise à jour sur son médicament candidat, lanifibranor, en amont des résultats principaux de l’étude de Phase 3 NATiV3 attendus au second semestre 2026 Trois experts internationaux de renom et un [...]
SoCalBio Investor & Partnership Conference to Feature Keynotes from SetPoint CEO Murthy Simhambhatla, PhD, and MedTech Industry Deal-Maker Ray Cohen
24/09/2025
Breakthrough Therapies and Life Sciences Leadership Take Center Stage October 1–2 in Newport Beach LOS ANGELES, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The Southern California Biomedical Council (SoCalBio) today announced [...]
New Report Offers Recommendations to Advance Brain Capital for Economic and Workforce Growth
24/09/2025
The Business Collaborative for Brain Health calls on global leaders to invest in workforce brain capital NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The Business Collaborative for Brain Health (BCBH), led by [...]
Unity Consortium Announces Bold Commitment to Empower Teen Vaccine Ambassadors at Clinton Global Initiative Meeting
24/09/2025
Launch of Trusted Teen CommUNITY Program to Reach 12 Million Annually NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Unity Consortium today announced the launch of its new Trusted Teen CommUNITY program. This ambitious [...]
Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on a like-for-like basis, mainly due to the decline in activity in France
24/09/2025
H1 2025 results Activity and profitability H1 revenue: €387.8 million, down 5.4% at CER 1 and on a like-for-like basis 2 , mainly due to the decline in activity in France Restated EBITDA margin 3 came out at 12.9%, [...]
Guerbet : Résultats semestriels 2025 : Chiffre d’affaires du 1er semestre : 387,8 M€, en retrait de 5,4% à TCC et périmètre comparable principalement en lien avec la baisse d’activité en France
24/09/2025
Résultats semestriels 2025 Activité et rentabilité Chiffre d’affaires du 1 er semestre : 387,8 M€, en retrait de 5,4% à TCC 1 et périmètre comparable 2 , principalement en lien avec la baisse d’activité en France La [...]
Eurobio Scientific : résultat du 1er semestre 2025
24/09/2025
RESULTAT DU 1 ER SEMESTRE 2025 Chiffre d’affaires en croissance de 10% à 80,7 M€ les produits propriétaires atteignent 36% du CA la part du CA hors France est de 42% Résultats 2025 impacté par le transfert de la [...]
EUROBIO SCIENTIFIC: RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025
24/09/2025
RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025 Revenue up 10% to €80.7 million Proprietary products account for 36% of revenue 42% of revenue generated outside France 2025 results impacted by the transfer of [...]
Booking Health Expands Access to Stage 4 Cancer Treatment in Germany
24/09/2025
Langenfeld, Germany, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Booking Health , a leading medical travel facilitator, has announced the expansion of its oncology services to improve international access to advanced stage 4 [...]
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations
24/09/2025
Press release – No. 14 / 2025 Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations Copenhagen, Denmark, September 24, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR [...]
The Association of American Physicians and Surgeons (AAPS) Supports Course Correction on Autism
24/09/2025
TUCSON, Ariz., Sept. 24, 2025 (GLOBE NEWSWIRE) -- In a joint appearance, President Donald Trump, HHS Secretary Robert F. Kennedy, Jr., NIH Director Jay Bhattacharya, FDA Commissioner Marty Makary, and CMS Director [...]
Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management
24/09/2025
PALO ALTO, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Pluristyx and Solesis Announce Strategic Collaboration to Advance Organoid and Cell Therapy Solutions
24/09/2025
SEATTLE and TELFORD, Pa., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pluristyx, Inc. and Solesis, LLC today announced the signing of a Memorandum of Understanding (MOU) establishing their strategic collaboration. The primary [...]
Financière de Tubize strengthens its expertise in the biopharma field by appointing 2 new directors
24/09/2025
Since the appointment of Bruno Holthof as Chairman of the Board of Directors of the company in April 2025, the company's board has continued to strengthen its expertise in the biopharma field. This aims to best support [...]
La Financière de Tubize renforce son expertise dans le domaine biopharma en nommant 2 nouvelles administratrices
24/09/2025
Depuis la nomination de Bruno Holthof comme président du conseil d'administration de la société en avril 2025, le conseil d’administration de la société poursuit le renforcement de son expertise dans le domaine [...]

Pages